Anthrax LFn-PA hybrid antigens: Biochemistry, immunogenicity, and protection against lethal Ames spore challenge in rabbits

Open Vaccine Journal

Volumn 2, Issue , 2009, Pages 92-99

  Li, Qin ^a   Peachman, Kristina K ^b   Sower, Laurie ^c   Leppla, Stephen H ^d   Shivachandra, Sathish B ^a   Matyas, Gary R ^e   Peterson, Johnny W ^c   Alving, Carl R ^e   Rao, Mangala ^e   Rao, Venigalla B ^a  

^a CATHOLIC UNIVERSITY OF AMERICA   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; ANTHRAX VACCINE; FURIN; LETHAL FACTOR PROTECTIVE ANTIGEN HYBRID PROTEIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BIOCHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; GENE FUSION; IMMUNITY; IMMUNOGENICITY; LD 50; LETHAL GENE; NONHUMAN; OLIGOMERIZATION; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; RABBIT;

EID: 77953435305     PISSN: None     EISSN: 18750354     Source Type: Journal    
DOI: 10.2174/1875035400902010092     Document Type: Article

References (48)

1. Young, J. A.; Collier, R.J. Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu. Rev. Biochem., 2007, 76, 243-265.
2. Moayeri, M.; Leppla, S.H. The roles of anthrax toxin in pathogenesis. Curr. Opin. Microbiol., 2004, 7(1), 19-24.
3. Bradley, K.A.; Mogridge, J.; Mourez, M.; Collier, R.J.; Young, J.A. Identification of the cellular receptor for anthrax toxin. Nature, 2001, 414 (6860), 225-229.
4. Scobie, H.M.; Rainey, G.J.; Bradley, K.A.; Young, J.A. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA, 2003, 100 (9), 5170-5174.
5. Klimpel, K.R.; Molloy, S.S.; Thomas, G.; Leppla, S.H. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc. Natl. Acad. Sci. USA, 1992, 89 (21), 10277-10281.
6. Beauregard, K.E.; Collier, R.J.; Swanson, J.A. Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization. Cell Microbiol., 2000, 2 (3), 251-258.
7. Collier, R.J.; Young, J.A. Anthrax toxin. Annu. Rev. Cell. Dev. Biol., 2003, 19, 45-70.
8. rd ed. Alouf JF, Popoff MR, Eds. Academic Press: Burlington, MA, 2006; pp. 323-347.
9. Banks, D.J.; Ward, S.C.; Bradley, K.A. New insights into the functions of anthrax toxin. Expert Rev. Mol. Med., 2006, 8 (7), 1-18.
10. Turnbull, P.C.; Broster, M.G.; Carman, J.A.; Manchee, R.J.; Melling, J. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect. Immun., 1986, 52 (2), 356-363.
11. Turnbull, P.C.; Leppla, S.H.; Broster, M.G.; Quinn, C.P.; Melling, J. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med. Microbiol. Immunol., 1988, 177 (5), 293-303. (Pubitemid 18201399)
12. Pitt, M.L.; Little, S.; Ivins, B.E.; Fellows, P.; Boles, J.; Barth, J.; Hewetson, J.; Friedlander, A.M. In vitro correlate of immunity in an animal model of inhalation anthrax. J. Appl. Microbiol., 1999, 87 (2), 304.
13. Williamson, E.D.; Hodgson, I.; Walker, N.J.; Topping, A.W.; Duchars, M.G.; Mott, J.M.; Estep, J.; Lebutt, C.; Flick-Smith, H.C.; Jones, H.E.; Li, H.; Quinn, C.P. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax. Infect. Immun., 2005, 73 (9), 5978-5987. (Pubitemid 41193036)
14. Scorpio, A.; Blank, T.E.; Day, W.A.; Chabot, D.J. Anthrax vaccines: Pasteur to the present. Cell Mol. Life Sci., 2006, 63 (19-20), 2237-2248.
15. Price, B.M.; Liner, A.L.; Park, S.; Leppla, S.H.; Mateczun, A.; Galloway, D.R. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect. Immun., 2001, 69 (7), 4509-4515.
16. Zhao, P.; Liang, X.; Kalbfleisch, J.; Koo, H.M.; Cao, B. Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model. Hum. Antibodies, 2003, 12 (4), 129-135. (Pubitemid 38657149)
17. Galloway, D.; Liner, A.; Legutki, J.; Mateczun, A.; Barnewall, R.; Estep, J. Genetic immunization against anthrax. Vaccine, 2004, 22 (13-14), 1604-1608.
18. Xu, Q.; Zeng, M. Detoxified lethal toxin as a potential mucosal vaccine against anthrax. Clin. Vaccine Immunol., 2008, 15 (14), 612-616. (Pubitemid 351967044)
19. Albrecht, M.T.; Li, H.; Williamson, E.D.; LeButt, C.S.; Flick-Smith, H.C.; Quinn, C.P.; Westra, H.; Galloway, D.; Mateczun, A.; Goldman, S.; Groen, H.; Baillie, L.W. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Infect. Immun., 2007, 75 (11), 5425-5433.
20. Shivachandra, S.B.; Li, Q.; Peachman, K.K.; Matyas, G.R.; Leppla, S.H.; Alving, C.R.; Rao, M.; Rao, V.B. Multicomponent anthrax toxin display and delivery using bacteriophage T4. Vaccine, 2007, 25 (7), 1225-1235.
21. Matyas, G.R.; Friedlander, A.M.; Glenn, G.M.; Little, S.; Yu, J.; Alving, C.R. Needle-free skin patch vaccination method for anthrax. Infect. Immun., 2004, 72 (2), 1181-1183.
22. Welkos, S.L.; Lowe, J.R.; Eden-McCutchan, F.; Vodkin, M.; Leppla, S.H.; Schmidt, J.J. Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene, 1988, 69 (2), 287-300. (Pubitemid 18243869)
23. Liu, S., T. H. Bugge, and S. H. Leppla. Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin. J. Biol. Chem., 2001, 276 (21), 17976-17984. (Pubitemid 37411359)
24. Robertson, D.L.; Leppla, S.H. Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis. Gene, 1986, 44 (1), 71-78. (Pubitemid 16032865)
25. Horton, R.M.; Hunt, H.D.; Ho, S.N.; Pullen, J.K.; Pease, L.R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene, 1989, 77 (1), 61-68
26. Melnyk, R.A.; Hewitt, K.M.; Lacy, D.B.; Lin, H.C.; Gessner, C.R.; Li, S.; Woods, Jr., V.L.; Collier, R.J. Structural determinants for the binding of anthrax lethal factor to oligomeric protective antigen. J. Biol. Chem., 2006, 281 (3), 1630-1635. (Pubitemid 43752479)
27. Park, S.; Leppla, S.H. Optimized production and purification of Bacillus anthracis lethal factor. Protein Exp. Purif., 2000, 18 (3), 293-302.
28. Ramirez, D.M.; Leppla, S.H.; Schneerson, R.; Shiloach, J. Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis. J. Ind. Microbiol. Biotechnol., 2002, 28 (4), 232-238. (Pubitemid 34461784)
29. Leppla, S.H. In Methods in enzymology; Harshman S, Ed. Production and purification of anthrax toxin. Academic Press: Orlando, FL 1988, Vol. 165, pp. 103-116.
30. Cameron, A.; Appel, J.; Houghten, R.A.; Lindberg, I. Polyarginines are potent furin inhibitors. J. Biol. Chem., 2000, 275 (47), 36741-36749. (Pubitemid 32002081)
31. Santelli, E.; Bankston, L.A.; Leppla, S.H.; Liddington, R.C. Crystal structure of a complex between anthrax toxin and its host cell receptor. Nature, 2004, 430 (7002), 905-908.
32. Mogridge, J.; Mourez, M.; Collier, R.J. Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin. J. Bacteriol., 2001, 183 (6), 2111-2116. (Pubitemid 32229126)
33. Peachman, K.K.; Rao, M.; Alving, C.R.; Burge, R.; Leppla, S.H.; Rao, V.B.; Matyas, G.R. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen. Infect. Immun., 2006, 74 (1), 794-797.
34. Hering, D.; Thompson, W.; Hewetson, J.; Little, S.; Norris, S.; Pace-Templeton, J. Validation of the anthrax lethal toxin neutralization assay. Biologicals, 2004, 32 (1), 17-27. (Pubitemid 38333181)
35. Peterson, J.W.; Comer, J.E.; Noffsinger, D.M.; Wenglikowski, A.; Walberg, K.G.; Chatuev. B.M.; Chopra, A.K.; Stanberry, L.R.; Kang, A.S.; Scholz, W.W.; Sircar, J. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax. Infect. Immun., 2006, 74 (2), 1016-1024. (Pubitemid 43185538)
36. Fokine, A.; Bowman, V.D.; Battisti, A.J.; Li, Q.; Chipman, P.R.; Rao, V.B.; Rossmann, M.G. Cryo-electron microscopy study of bacteriophage T4 displaying anthrax toxin proteins. Virology, 2007, 367 (2), 422-427.
37. Lacy, D.B.; Lin, H.C.; Melnyk, R.A.; Schueler-Furman, O.; Reither, L.; Cunningham, K.; Baker, D.; Collier, R.J. A model of anthrax toxin lethal factor bound to protective antigen. Proc. Natl. Acad. Sci. USA, 2005, 102 (45), 16409-16414. (Pubitemid 41688927)
38. Sellman, B.R.; Nassi, S.; Collier, R.J. Point mutations in anthrax protective antigen that block translocation. J. Biol. Chem., 2001, 276 (11), 8371-8376. (Pubitemid 37385648)
39. Miller, C.J.; Elliott, J.L.; Collier, R.J. Anthrax protective antigen: prepore-to-pore conversion. Biochemistry, 1999, 38 (32), 10432-10441. (Pubitemid 129515383)
40. Liu, S.; Leung, H.J.; Leppla, S.H. Characterization of the interaction between anthrax toxin and its cellular receptors. Cell. Microbiol., 2007, 9 (4), 977-987.
41. Belton, F.C.; Strange, R.E. Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production. Br. J. Exp. Pathol., 1954, 35 (2), 144-152.
42. Puziss, M.; Manning, L.C.; Lynch, Barclaye, J.W.; Abelow, I.; Wright, G.G. Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures. Appl. Microbiol., 1963, 11, 330-334.
43. Turnbull, P.C. Anthrax vaccines: past, present and future. Vaccine, 1991, 9 (8), 533-539.
44. Pittman, P.R.; Kim-Ahn, G.; Pifat, D.Y.; Coonan, K.; Gibbs, P.; Little, S.; Pace-Templeton, J.G.; Myers, R.; Parker, G.W.; Friedlander, A.M. Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans. Vaccine, 2002, 20 (9-10), 1412-1420.
45. Pile, J.C.; Malone, J.D.; Eitzen, E.M.; Friedlander, A.M. Anthrax as a potential biological warfare agent. Arch. Intern. Med., 1998, 158 (5), 429-434. (Pubitemid 128681603)
46. Zomber, G.; Reuveny, S.; Garti, N.; Shafferman, A.; Elhanany, E. Effects of spontaneous deamidation on the cytotoxic activity of the Bacillus anthracis protective antigen. J. Biol. Chem., 2005, 280 (48), 39897-39906. (Pubitemid 41779124)
47. Tama, F.; Ren, G.; Brooks, C.L. 3rd, Mitra AK. Model of the toxic complex of anthrax: responsive conformational changes in both the lethal factor and the protective antigen heptamer. Protein Sci., 2006, 15 (9), 2190-2200.
48. Phipps, A. J.; Premanandan, C.; Barnewall, R.E.; Lairmore, M.D. Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines. Microbiol. Mol. Biol. Rev., 2004, 68 (4), 617-629.